Hikma Adds Another Celltrion Biosimilar To MENA Collaboration
Also Launches Pre-Filled Syringe Version Of Naloxone 2mg/2ml In US
Hikma has further expanded its portfolio of biosimilars in the MENA region with the addition of Celltrion’s Vegzelma bevacizumab rival to Avastin. Meanwhile, Hikma has also just launched a new pre-filled syringe version of naloxone in the US.
